Clinical Trial Update: Veliparib and Temozolomide in Treating Patients With Acute Leukemia [Phase 1]

View source ↗

Summary

Phase 1 study of veliparib plus temozolomide in adults with acute lymphoblastic leukemia or acute myeloid leukemia has completed enrollment, focusing on safety …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia

Drugs mentioned

• Temozolomide (Temozolomide)
• Veliparib (veliparib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | Phase 1 | Status: COMPLETED